Galera Therapeutics, Inc.
USD0.10
+0.00 (+1.00%)
CEO
J. Mel Sorensen
IPO Date
2019-11-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.10
Prev. Close
$0.10
Day Low
$0.10
Day High
$0.10
52W Low
$0.01
52W High
$0.15
Market Cap
$0.01B
Volume
0.01M
| 20,813.819 |
| $0.00 |
| 4 May 2026 | Emerald Bioventures, LLC | 10 percent owner | Disposed | 0 | $0.00 |
| 4 May 2026 | Emerald Bioventures, LLC | 10 percent owner | Disposed | 20,813,818.6 | $0.00 |
| 9 Apr 2026 | FRIEDMAN MICHAEL R. | director | C-Conversion | Acquired | 5,336,870 | $0.00 |
| 9 Apr 2026 | FRIEDMAN MICHAEL R. | director | C-Conversion | Disposed | 5,336.87 | $0.00 |
| 9 Apr 2026 | CHANG NANCY T | director, 10 percent owner: | C-Conversion | Acquired | 1,180,611 | $0.00 |
| 9 Apr 2026 | CHANG NANCY T | director, 10 percent owner: | C-Conversion | Disposed | 1,180.611 | $0.00 |
| 24 Nov 2025 | Sorensen Mel | director, officer: President and CEO | S-Sale | Disposed | 70,000 | $0.02 |
| 5 May 2025 | Sussman Joel F. | Chief Accounting Officer | A-Award | Acquired | 2,000,000 | $0.02 |